Show Results For
-
All HBS Web
(1,031)
- People (7)
- News (394)
- Research (419)
- Multimedia (8)
- Faculty Publications (117)
Show Results For
-
All HBS Web
(1,031)
- People (7)
- News (394)
- Research (419)
- Multimedia (8)
- Faculty Publications (117)
- May 2024
- Case
Choosing the Course of Passion: Brooke Boyarsky Pratt at knownwell
- December 2005 (Revised August 2006)
- Case
Amgen Inc.'s Epogen--Commercializing the First Biotech Blockbuster Drug
- 21 Aug 2015
- Blog Post
My Fear of Student Debt: Funding the HBS/HKS Joint Degree
- May 2021
- Supplement
Paul Levy: Confronting a 'Corporate Campaign' (B)
- 09 Jun 2016
- Blog Post
Pursuing an Interest in Nonprofits at HBS
Brian L. Trelstad
Brian Trelstad is a Senior Lecturer at Harvard Business School in the General Management Unit and the Faculty Chair of the Advanced Leadership Initiative. He teaches elective courses on Social Entrepreneurship and Systems... View Details
- 26 Mar 2014
- Research & Ideas
How Electronic Patient Records Can Slow Doctor Productivity
- Career Coach
Doug Lester
- 10 Mar 2020
- News
Sorry, but Working From Home Is Overrated
- 21 Jan 2021
- Blog Post
How I Used the HBS Community to Hone My Professional Goals
- Article
The Economic Consequences of Hospital Admissions
- January 2014 (Revised December 2014)
- Case
GenapSys: Business Models for the Genome
GenapSys, a California-based startup, was soon to release a new DNA sequencer that the company's founder, Hesaam Esfandyarpour, believed was truly revolutionary. The sequencer would be substantially less expensive—potentially costing just a few thousand dollars—and... View Details
- 19 May 2015
- First Look
First Look: May 19
Paul A. Gompers
- Career Coach
Betsy Edwards
- 27 Jul 2011
- Research & Ideas
Customer Loyalty Programs That Work
- Program
Program for Leadership Development
- July 2014
- Case
BMVSS: Changing Lives through Innovation One Jaipur Limb at a Time (Abridged)
- September 2013
- Article
Testimonials Do Not Convert Patients from Brand to Generic Medication
Objectives: To assess whether the addition of a peer testimonial to an informational mailing increases conversion rates from brand name prescription medications to lower-cost therapeutic equivalents, and whether the testimonial's efficacy increases when... View Details
- 25 Jun 2013
- First Look